Dietary fiber of Tartary buckwheat bran modified by steam explosion alleviates hyperglycemia and modulates gut microbiota in db/db mice.
Level 5 - mechanism / opinion, no new human data
Animal research (db/db mouse model)
PubMed 35761642 · doi:10.1016/j.foodres.2022.111386
What was done
Diabetic db/db mice were administered steam explosion-modified soluble dietary fiber from Tartary buckwheat bran (SE-SDF). The authors evaluated glycemic indices (fasting blood glucose, glycosylated hemoglobin, oral glucose tolerance, insulin resistance), tissue damage (liver, pancreas, colon), hepatic protein markers (PI3K, GPR43, p-AMPK, FoxO1, PEPCK, G-6-Pase), fecal short-chain fatty acids (SCFAs), colonic GPR43, serum GLP-1, and gut microbiota profile.
What was found
The abstract reports no numerical values or effect sizes. Directionally, SE-SDF decreased fasting blood glucose and glycosylated hemoglobin, improved oral glucose tolerance, reduced insulin resistance, and alleviated tissue injuries in the liver, pancreas, and colon. It up-regulated hepatic PI3K, GPR43, and p-AMPK expression while down-regulating FoxO1, PEPCK, and G-6-Pase. Additionally, it elevated fecal SCFAs, colon GPR43, and serum GLP-1, reduced the Firmicutes/Bacteroidetes ratio, and increased the relative abundance of Parabacteroides, norank_f_Muribaculaceae, Alloprevotella, Ruminiclostridium_9, unclassified_f_Ruminococcaceae, and Lachnospiraceae_NK4A136_group.
Why it matters
It outlines a potential gut microbiota-SCFA-liver signaling mechanism through which modified buckwheat bran fiber could aid glycemic regulation in type 2 diabetes models.
Limits
The study is restricted to an animal model (db/db mice) with no human validation. The abstract omits sample size (n), treatment duration, dosage, comparator details, and quantitative effect estimates.
Cited by
- supports The polyphenols and fiber in Himalayan tartary buckwheat modulate the microbiome in ways that assist blood sugar control.